The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Fri, 01st Oct 2021 11:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Sensyne Health PLC - Oxford-based healthcare technology company - Reports revenue growth to GBP9.1 million in the financial year to April 30 from GBP2.1 million posted the year earlier. The company says it increased patient records to 8.9 million by April 30 from 2.8 million the year before through signing of five new strategic research agreements in the UK. Pretax loss, however, widens to GBP28.4 million from GBP22.6 million year-on-year, as research & development expenses climb to GBP16.0 million from GBP11.1 million. Other general & administration expenses also increase to GBP15.0 million from GBP9.8 million in financial 2020.

----------

Stranger Holdings PLC - London-based investment company - Reports narrowed pretax loss for the financial year to March 31 of GBP432,000 versus GBP505,000 loss recorded the year earlier, arising predominantly from reverse takeover costs and listing fees on the London Stock Exchange together with costs in connection with the aborted acquisition of Recyclus. The reverse takeover transaction has been terminated due to the non-performance of Recyclus, the company says. Last Sunday, the company says it entered into a memorandum of understanding with Mayflower Capital Investments Pty Ltd for the acquisition of mineral rights in Africa, to include commodities such as tin and uranium.

----------

VietNam Holding Ltd - Guernsey-based closed-end fund - Reports net asset value per share as at June 30 of GBP3.330 compared to GBP1.868 the year before. The company's share price at the end of its financial year on June 30 stands at 265.0 pence, representing a 20% discount to NAV. VietNam says it continues to focus on narrowing the discount and has utilised three main discount control measures: marketing, share buybacks and tender offers.

----------

Gulf Marine Services PLC - United Arab Emirates-based vessels operator - Confirms the underlying trading performance of the business remains in line with management expectations. For the six months to June 30, revenue increased to USD51.4 million from USD49.8 million a year before. Earnings before interest, tax, depreciation and amortization increased by 16% to USD26.5 million from USD22.9 million year-on-year. The company explains that market demand is being supported by commodity prices, driving renewed interest in capital expenditure work, combined with ongoing maintenance activity.

----------

Empire Metals Ltd - London-based exploration & resource development company - Reports "encouraging" results of the recently completed soil sampling programme at the Central Menzies gold project in Western Australia. The company says 2,379 metres of reverse circulation was drilling completed, focusing on the most promising two of the previously identified mineralised trends, respectively known as Teglio and Nugget Patch. The results of the soil sampling programme have helped identify several drilling targets, the company says, which will be further evaluated and prioritised once the results of the initial reverse circulation drilling programme are returned.

----------

Gateley Holdings PLC - London-based legal services provider - Reports trading in the first five months of the financial year is in line with management's expectations. "The board remains excited by a wide range of growth opportunities and is looking forward to continuing to grow the group, both organically and via acquisition, in line with our stated strategy," says Chair Nigel Payne.

----------

Begbies Traynor Group PLC - Manchester-based firm specialising in corporate restructuring - Says Eddisons, the property services consultancy division of Begbies Traynor, reports the expansion of its operations in Sheffield through the acquisition of the team from Fernie Greaves Chartered Surveyors. The company will pay GBP250,000 from its existing financial resources. The acquisition will expand Eddisons' presence in South Yorkshire, which provides real estate consultancy services through its existing team headed by Adrian Lunn.

----------

Semper Fortis Esports PLC - London-based professional esports team operator - Reports induction into the official Rocket League Esports Shop for the upcoming Rocket League Championship Series season. The company says it will now be able to provide its fans with the opportunity to represent the team through the purchase of customised in-game cars to generate revenue for the company.

----------

ReNeuron Group PLC - Bridgend, Wales-based biotechnology company - Receives regulatory approval to restart the phase 2a clinical evaluations for the treatment of retinitis pigmentosa, an eye disease, in all geographies. Recruitment for the study has resumed, with two patients scheduled to be treated in October and all remaining patients expected to be treated by the end of 2021. The company says it now expects to present early efficacy data on the expansion cohort in the first quarter of 2022 and remains on track for advancing the programme into the next clinical trial by the end of 2022.

----------

Pires Investments PLC - London-based technology-focused investment company - Says its portfolio company Pluto Digital Assets PLC acquired the assets of the innovative DeFi project, yield optimisation platform. Pluto intends to reimagine, redevelop and relaunch the yield optimisation platform and to support the existing protocol, community and yield optimization platform, or YOP, token. "Following shortly after the announcement of its partnership in the NFT space, this acquisition clearly demonstrates the rapid progress that Pluto is continuing to make in this very exciting sector," says Pires Director Nicholas Lee.

----------

Panther Metals PLC - Malaysia-based company focused on mineral exploration in Canada and Australia - Reports the appointment of Rugged Aviation Inc to conduct the proposed diamond drilling programme targeting volcanogenic massive sulphide mineralisation at Panther's Wishbone VMS prospect at the Obonga project in Ontario, Canada. "With a drilling permit already in place and our supportive shareholders, we have been able to act efficiently and award the Wishbone diamond drilling contract to take advantage of the autumn weather window," says Panther Chief Executive Darren Hazelwood.

----------

Live Co Group PLC - Surrey-based events and entertainment company - Signs a new contract with Eastleigh BID for Bricklive the March of the Penguins. This will be the first time that the company has worked with Eastleigh, who plan to show the models in throughout Eastleigh Town centre in Hampshire. The penguins will be installed on November 19 ahead of the Eastleigh BID Christmas light switching on event.

----------

Gresham House PLC - London-based asset manager - Reports completion of the acquisition of the Venture Capital Trust business of Mobeus Equity Partners LLP. Mobeus is a UK-based investment firm managing assets across two distinct client groups, one of which is the VCT business being acquired by Gresham House. The four VCTs whose contracts are being acquired are: Mobeus Income & Growth VCT PLC, Mobeus Income & Growth 2 VCT PLC, Mobeus Income & Growth 4 VCT PLC, and Income & Growth VCT PLC, with a combined assets under management of GBP369 million.

----------

San Leon Energy PLC - Dublin-based oil & gas exploration company - Says investee Decklar Resources Inc reports the Oza-1 well re-entry at the Oza oil field in Nigeria. Decklar has tested the remaining two sands, the L2.4 and the L2.2. During the initial flow testing of the L2.4 sand, the zone produced at multiple choke settings ranging from 16/64 inch to 28/64 inch over the 25 hour testing period. During the initial flow testing of the L2.2 sand, the zone produced at multiple choke settings ranging from 16/64 to 28/64 inch over the 46 hour initial test period. Decklar is evaluating artificial lift strategies such as gas lift to enhance well productivity and plans to develop the L2.2 sand by drilling a horizontal well from the Oza-1 well pad drilling slot location.

----------

Scirocco Energy PLC - company which invests in European energy assets - Reports the completion of the acquisition of Greenan Generation Ltd and its 0.5 megawatts anaerobic digestion plant in Northern Ireland by Energy Acquisition Group Ltd. Scirocco holds a 50% interest in Energy Acquisition Group. The anticipated gross initial annual turnover from Greenan Generation is c. GBP1.1 million.

----------

Inland Homes PLC - Beaconsfield, England-based housebuilder - Reports the sale of 228 plots at the former Homebase site in Walthamstow to the housing association Newlon Build Ltd. The sale is for GBP22.5 million and generates fees of GBP1.2 million for Inland Homes.

In addition, the company says it has separately secured a build contract for Inland Partnerships to construct the 228 homes, adding GBP42.4 million to its forward order book for partnership housing and bringing the total number of homes under construction on behalf of third parties to 1,358.

----------

Alumasc Group PLC - Kettering, England-based supplier of building and engineering products - Says Gatic, a part of the company's Water Management division, has been awarded a number of new contracts in the Middle East and Far East. The sales value of these orders total in excess of GBP3.5 million. These contracts are for the supply of Gatic access and drainage products for a number of projects, including further Gatic access covers for the third runway at Chek Lap Kok airport in Hong Kong, Gatic access cover sales to Doha, Qatar, and Gatic Slotdrain sales to the South Harbour Expansion in Manila, the Philippines. Supply has already commenced, and these contracts are expected to be delivered over the next 12 months.

----------

Prospex Energy PLC - Hatfield, England-based investment company - Says its joint venture company Tarba Energia SL has contracted the well intervention work and a programme for system optimisation and automation at its gas to power project at El Romeral in Southern Spain. Upon success, the well workover has the potential to increase gas production by up to 15,000 cubic metres per day to 27,000 cubic metres per day and would allow the subsequent start-up of a second generator to double electrical output. In addition, the system optimisation project is expected to boost income from power generation by up to 65%.

----------

Coro Energy PLC - London-based low carbon investment company - Reports an extension of the exclusivity period agreed with the company's Vietnamese rooftop solar project partner Vinh Phuc Electrical Mechanical Installation Co Ltd until October 31. Coro explains that current in-country Covid-19 restrictions, including limitations on being able to formally lodge papers with the Vietnamese government, have meant that Coro now expects a definitive joint venture agreement to be capable of entry by the end of October.

----------

Malin Corp PLC - Irish company which invests in life sciences firms - Reports the completion of sale of its investee company subsidiary Altan Pharma to Ethypharm. Malin owned 65% of Altan and the sale of Altan delivers net proceeds to Malin of EUR68.1 million after the repayment of Altan's net debt and the payment of transaction related costs. Following the completion of the Altan sale, Malin has a cash balance of EUR118 million. The company intends to initiate a significant return of capital to its shareholders before the end of 2021, with the intention of returning the majority of current cash.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Apr 2019 10:55

ReNeuron Signs Licence Deal For CTX, hRPC Cell Programmes In China

LONDON (Alliance News) - ReNeuron Group PLC on Tuesday said it has signed an exclusive licence agreement for the development, manufacture and commercialisation of its CTX and hRPC cell therapy in

Read more
4 Apr 2019 14:19

ReNeuron upbeat on progress in hRPC study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on progress with its ongoing phase 1 and 2 clinical trial in the US of its 'hRPC' cell therapy candidate in the blindness-causing disease retinitis pigmentosa (RP) on Thursday, confirming that the positive efficacy seen and previously announced had, to date, been sustained in the first patient cohort in the phase 2 part of the study.

Read more
4 Apr 2019 10:32

ReNeuron Shares Rise On Positive Data From Blindness Treatment Trial

LONDON (Alliance News) - Shares rose in ReNeuron Group PLC on Thursday after it reported positive efficacy in a phase one/two clinical trial of its hRPC cell therapy candidate for treating in the

Read more
18 Mar 2019 11:42

ReNeuron Group Starts Dosing Of Second Cohort In hRPC Study

LONDON (Alliance News) - ReNeuron Group PLC on Monday said it started dosing of the second cohort of patients in a phase II study of its hRPC cell therapy candidate in the blindness-causing of in

Read more
18 Mar 2019 11:33

ReNeuron Group begins dosing second cohort in hRPC study

(Sharecast News) - Cell-based therapeutics company ReNeuron Group updated the market on progress with the ongoing phase 1 and 2 clinical trial in the US of its 'hRPC' cell therapy candidate in the blindness-causing disease, retinitis pigmentosa (RP).

Read more
20 Feb 2019 09:47

ReNeuron Reports Positive Preliminary Data In US Retinal Trial

LONDON (Alliance News) - ReNeuron Group PLC on Wednesday reported "significant improvement in vision" in the trial of its hRPC cell therapy candidate for retinal disease.ReNeuron

Read more
20 Feb 2019 08:21

ReNeuron storms on 'exciting' eye disease trial success

(Sharecast News) - ReNeuron Group bounded upward on Wednesday after reporting that its cell-based therapy is showing signs that it can improve the sight of patients suffering from retinitis pigmentosa, which causes blindness.

Read more
31 Jan 2019 09:55

ReNeuron upbeat on data around ease of exosome manufacture

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Thursday that new data relating to the manufacturing scale-up of its GMP produced, CTX-derived exosomes was being presented at a US forum on the manufacture of cell and gene therapies.

Read more
24 Jan 2019 12:16

ReNeuron Group Reports First Enrolled Patient In Stroke Clinical Trial

LONDON (Alliance News) - ReNeuron Group PLC on Thursday said it enrolled the first patient in its US Phase IIb clinical study of CTX stem cell therapy for stroke disability.The study is a 6

Read more
24 Jan 2019 09:46

First patient dosed in latest ReNeuron study of CTX cell therapy

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Thursday that the first patient has been treated in the US Phase IIb clinical study of its 'CTX' cell therapy candidate for stroke disability.

Read more
4 Jan 2019 07:59

ReNeuron Group to collaborate with unnamed US biopharmaceutical firm

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group has signed a collaboration agreement with an unnamed US-based biopharmaceutical company to explore the use of its exosome technology platform as a potential delivery vehicle for synthetic oligonucleotides used in gene therapy, it announced on Friday.

Read more
14 Dec 2018 12:07

ReNeuron narrows losses as development programmes continue

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group issued its interim results for the six months ended 30 September on Friday, reporting a reduced loss for the period of £5.32m, from £9.57m year-on-year.

Read more
7 Dec 2018 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 10 December Photo-Me InternationalHalf Year ResultsHollywood Bowl GroupFull Year

Read more
18 Oct 2018 12:42

Reneuron's stem cell technology could produce cancer-combating cells

(Sharecast News) - New data from a study by Reneuron has encouraged the company that its stem cell technology could be adapted to specifically attack cancerous cells.

Read more
18 Oct 2018 10:54

ReNeuron Reports New Positive Data Relating To CTX Stem Cell Platform

LONDON (Alliance News) - ReNeuron Group PLC on Thursday said its CTX stem cell therapy candidate can be successfully re-programmed to a pluripotent state.Pluripotent state is an embryonic a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.